HypertensionPROPHYL HONCT00695266
National Survey on Hypertension at Hospital
An observational study of Hypertension, run by AstraZeneca at 113 sites in France.
Trial summary
To evaluate (with sufficient accuracy) the profile(demographic and clinical characteristics, health care management) of hypertensive patients seen in hospital out patient's department by a cardiologist or a nephrologists. Read more about this study
- Who is it for?
- Ages 18 years and older
- Conditions the study is for
- Hypertension
- How many people
- 655 participants
- Where
- 113 sitesFrance
- Study dates
- Dec 2007to Sep 2008
- Phase
- Observational
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 years and older
- All sexes
- No healthy volunteers
- Adult, Older adult
Study population: First five consecutive patients with hypertension seen by Cardiologists
Who may be able to join
- Known hypertension
- agree to take part in this study
Who cannot join
- none
Trial locations and contacts
113 sites in 1 country.
113 sites in 1 country
France113 sites
Research Site
Abreschviller
Research Site
Aix-en-Provence
Research Site
Ajaccio
Research Site
Ambilly
Research Site
Annecy
Research Site
Auch
Research Site
Auxerre
Research Site
Bar-le-Duc
Research Site
Bastia
Research Site
Bobigny
Research Site
Bourges
Research Site
Bron
Research Site
Bry-sur-Marne
Research Site
Cahors
Research Site
Caluire-et-Cuire
Research Site
Cambo-les-Bains
Research Site
Cambrai
Research Site
Chalon-sur-Saône
Research Site
Chambéry
Research Site
Chambray-lès-Tours
Research Site
Champigny-sur-Marne
Research Site
Charleville-Mézières
Research Site
Châteauroux
Research Site
Chaumont
Research Site
Chauny
Research Site
Cholet
Research Site
Colmar
Research Site
Corbeil-Essonnes
Research Site
Creil
Research Site
Créteil
Research Site
Dax
Research Site
Dechy
Research Site
Décines-Charpieu
Research Site
Dieppe
Research Site
Dijon
Research Site
Dunkirk
Research Site
Eaubonne
Research Site
Évecquemont
Research Site
Évian-les-Bains
Research Site
Firminy
Research Site
Forbach
Research Site
Freyming-Merlebach
Research Site
Gap
Research Site
Givors
Research Site
Gleizé
Research Site
Gonesse
Research Site
Grenoble
Research Site
Haguenau
Research Site
Hyères
Research Site
La Rochelle
Research Site
La Source
Research Site
Lagny-sur-Marne
Research Site
Langres
Research Site
Lannion
Research Site
Laon
Research Site
Laval
Research Site
Le Chesnay
Research Site
Le Puy-en-Velay
Research Site
Libourne
Research Site
Limoges
Research Site
Lunéville
Research Site
Lyon
Research Site
Marseille
Research Site
Martigues
Research Site
Melun
Research Site
Metz
Research Site
Mont-de-Marsan
Research Site
Montfermeil
Research Site
Montivilliers
Research Site
Montpellier
Research Site
Montreuil
Research Site
Nice
Research Site
Nîmes
Research Site
Niort
Research Site
Orange
Research Site
Oyonnax
Research Site
Paray-le-Monial
Research Site
Paris
Research Site
Pau
Research Site
Périgueux
Research Site
Pessac
Research Site
Pierre-Bénite
Research Site
Poissy
Research Site
Pontault-Combault
Research Site
Provins
Research Site
Roanne
Research Site
Saint-Amand-Montrond
Research Site
Saint-Avold
Research Site
Saint-Herblain
Research Site
Saint-Martin-d'Aubigny
Research Site
Saint-Priest-en-Jarez
Research Site
Saint-Quentin
Research Site
Sallanches
Research Site
Salouël
Research Site
Sarreguemines
Research Site
Schiltigheim
Research Site
Semur-en-Auxois
Research Site
Senlis
Research Site
Sisteron
Research Site
Strasbourg
Research Site
Suresnes
Research Site
Tarbes
Research Site
Thiais
Research Site
Toulon Armees
Research Site
Toulouse
Research Site
Tours
Research Site
Tracy-le-Mont
Research Site
Trappes
Research Site
Tulle
Research Site
Vandœuvre-lès-Nancy
Research Site
Vénissieux
Research Site
Villenave-d'Ornon
Research Site
Villeneuve-Saint-Georges
About this study
Official title: Profile of Hypertensive Patients Seen in Hospital Outpatient's Department
To evaluate (with sufficient accuracy) the profile(demographic and clinical characteristics, health care management) of hypertensive patients seen in hospital out patient's department by a cardiologist or a nephrologists.
- Conditions
- Hypertension
- Medical subject headings
- Hypertension
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
| Study group | Role | What they receive |
|---|---|---|
| 1 | Not described |
What is being measured
The primary outcome is the main question the study is designed to answer.
Demographic, clinical and health care characteristics
Measured: Once
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted11 Jun 2008 (estimated)
- Study startDec 2007
- Study completionSep 2008
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for HypertensionStudies of the same condition, open and under way.
- More trials run by AstraZenecaThe sponsor's other registered studies.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Observational
- Observational model
- Cohort
- Time perspective
- Prospective
- Enrolment
- 655 participants (actual)
Sponsor and investigators
- Lead sponsor
- AstraZeneca
- Sponsor type
- Industry (pharma, biotech, devices)
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT00695266
- Sponsor's protocol ID
- NIS-CFR-DUM-2007/5
- Acronym
- PROPHYL HO
- Status last verified
- Aug 2009
- First submitted
- 9 Jun 2008
- Last updated
- 6 Aug 2009
- Results posted
- No
- Data monitoring committee
- No
Study at a glance
From the registry record, last updated by the sponsor on 6 Aug 2009. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Profile of Hypertensive Patients Seen in Hospital Outpatient's Department
- ClinicalTrials.gov ID
- NCT00695266
- Acronym / sponsor ID
- PROPHYL HO / NIS-CFR-DUM-2007/5
- Conditions
- Hypertension
- Study type
- Observational
- Recruitment status
- Completed
- Enrolment
- 655 participants (actual)
- Lead sponsor
- AstraZenecaIndustry (pharma, biotech, devices)
- Study start
- Dec 2007
- Study completion
- Sep 2008 (actual)
- First posted
- 11 Jun 2008 (estimated)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
To evaluate (with sufficient accuracy) the profile(demographic and clinical characteristics, health care management) of hypertensive patients seen in hospital out patient's department by a cardiologist or a nephrologists.
Study design
- Observational model
- Cohort
- Time perspective
- Prospective
- Number of arms
- 1
| Arm | Type | Receives |
|---|---|---|
| 1 | – | – |
Who may qualify
- Ages
- 18 years and older
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Adult, Older adult
- Study population
- First five consecutive patients with hypertension seen by Cardiologists
Key inclusion criteria (2 listed)
- Known hypertension
- agree to take part in this study
Key exclusion criteria (1 listed)
- none
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Primary outcome
Demographic, clinical and health care characteristics
Time frame: Once
Results and safety
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 6 Aug 2009.
Related trials for Hypertension
Active, not recruiting
Digital Reinforcement of Motivational Interviewing Micro-Skills Among Primary Care Healthcare Professionals
Hypertension (Without Type 2 Diabetes Mellitus)
Recruiting
Investigating Vascular Properties of HEMI and SPG Signals in Individuals With or at Risk for Chronic Kidney Disease
Chronic Kidney Disease, Hypertension (HTN)
Recruiting
Trial Phase: Syndemic Adapted Medly Uganda
Mental Health
Not yet recruitingPhase 2/3
An Open-Label Extension Study to Evaluate Inhaled Treprostinil SMI in Participants With Pulmonary Hypertension Associated With Chronic Obstructive Pulmonary Disease (PH-COPD)
Pulmonary Hypertension Associated With Chronic Obstructive Pulmonary Disease
Enrolling by invitation
Testing Implementation Strategies to Support Clinic Fidelity to an Outpatient Hypertension Bundle
Pregnancy Related, Hypertension
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
The record lists no contact. Use the official record to reach the sponsor.
113 sites in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
An observational study of Hypertension, run by AstraZeneca at 113 sites in France.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 2 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 6 Aug 2009. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 113 sites in France. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Demographic, clinical and health care characteristics (time frame: Once). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 6 Aug 2009.